Tag: RSV

Promising Trial Results of Drug to treat RSV Published in the New England Journal of Medicine

Written by Communications and Marketing

|
Research

A new antiviral drug, ALS-008176, designed to fight respiratory syncytial virus (RSV) has shown potential against RSV infection. The medicine, developed by Alios Biopharma Inc., one of the Janssen Pharmaceutical Companies, in collaboration with laboratories at Le Bonheur Children’s Hospital and physicians from the University of Tennessee Health Science Center, could re-define how physicians worldwide… Read More

UT Institute for Research, Innovation, Synergy and Health Equity Announces Six Grant Awards Totaling $402,000

Written by Communications and Marketing

|
Research

The UT Institute for Research, Innovation, Synergy and Health Equity (iRISE) at the University of Tennessee Health Science Center (UTHSC) has announced the latest round of grant recipients from its Pilot Translational and Clinical Studies (PTCS) Program. Six UTHSC researchers were chosen out of a competitive field of 28 submissions. The PTCS Program provides funding and… Read More